ACET - CIK 0001720580
The table below shows Adicet Bio, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $36.24M | $29.10M | $34.72M | $28.13M | $105.48M | $224.07M |
| Short-term investments | - | - | - | - | $96.58M | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $140.07M |
| $106.49M |
| $127.74M |
| $153.56M |
| $206.32M |
| $228.35M |
| Property, plant & equipment | $15.18M | $17.99M | $19.55M | $21.11M | $24.09M | $24.04M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $169.38M | $140.48M | $162.97M | $191.27M | $245.96M | $268.84M |
| Accounts payable | $2.93M | $4.29M | $3.29M | $4.40M | $2.50M | $1.90M |
| Total current liabilities | $18.30M | $18.94M | $17.08M | $16.45M | $19.39M | $17.90M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $29.32M | $31.34M | $29.60M | $29.82M | $34.43M | $33.73M |
| Retained earnings | -$634.94M | -$584.18M | -$557.33M | -$526.11M | -$469.17M | -$438.69M |
| Total equity | $140.06M | $109.14M | $133.37M | $161.45M | $211.53M | $235.11M |